SARS-CoV-2 infection activating a novel variant of the NOTCH3 gene and subsequently causing development of CADASIL
Description
CONCLUSIONS: It seems therefore that the new variant of NOTCH3 is of de novo origin in the patient's genome. Additionally, the relatively early onset of CADASIL and the unexpectedly severe COVID-19 infection suggest that the two occurred
